z-logo
open-access-imgOpen Access
Methods Development and Modeling Research: Contributions to Advancing TRS and Informing Regulations
Author(s) -
Simani Price,
Melanie C Chansky,
Helen I. Meissner,
Martha C. Engstrom,
Tara Dunderdale,
Rachel Grana Mayne,
Ami L. Bahde,
Joy A. Frechtling,
Rachel J Mandal
Publication year - 2020
Publication title -
tobacco regulatory science
Language(s) - English
Resource type - Journals
ISSN - 2333-9748
DOI - 10.18001/trs.6.6.7
Subject(s) - regulatory science , portfolio , food and drug administration , drug development , political science , business , engineering ethics , computer science , medicine , pharmacology , drug , risk analysis (engineering) , engineering , finance , pathology
The US Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) funds a wide range of research studies. Methods development and modeling research (MDMR) are 2 areas of interest, as they can help advance tobacco regulatory science (TRS) by fostering data synthesis and exploration of complex relationships. Our analyses of the CTP portfolio found that 13% of publications focused on MDMR, and the most commonly addressed CTP priority research domains were knowledge, attitudes, and behaviors, and toxicity and carcinogenicity. MDMR publications were cited by 1,186 publications, 5 FDA proposed rules and guidance documents, and 3 dockets. MDMR publications are characterized as foundational research and help build the evidence base that informs policy. While MDMR represents a small portion of the CTP research portfolio, they have made important contributions to advancing TRS and informing regulatory actions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here